Evidence-based supplements, vitamins, minerals, nootropics, and longevity interventions
208 articles
A market analysis of 62 hangover products across UK, Australia, and Japan reveals striking ingredient differences and a complete absence of clinical trial evidence.
A Cochrane review of 107 RCTs finds vitamin D may slightly cut ARI-related doctor visits in under-5s, but evidence remains low-certainty.
A comprehensive historical review traces how sublingual and buccal drug delivery evolved from steroids to nanoparticles, bypassing first-pass metabolism.
Coating dental floss with vaccine antigens targets the gingival sulcus, triggering robust mucosal and systemic immunity comparable to intranasal vaccination.
A major review finds clinical proof for NAD+ decline with age is sparse, and human trials of NR and NMN show limited efficacy.
A product review breaks down the evidence tiers for four popular longevity supplements and rates the best commercial stacks.
A leading aging researcher audits NMN, urolithin A, spermidine, and more — revealing what actually works and what falls short.
A Stanford drug development expert breaks down why most peptide compounds circulating online lack the safety and efficacy data required for human use.
A novel two-stage fermentation process produces record levels of PQQ and single cell protein using agricultural waste, cutting production costs.
Pyrroloquinoline quinone at 5 μM improved porcine oocyte maturation, reduced ROS, and raised blastocyst formation rates in a new lab study.
Expert reviews compare leading senolytic and NAD+ supplement brands on ingredients, evidence quality, and value.
New expert reviews compare NMN and NR head-to-head, ranking top products by purity, absorption, and clinical evidence.
